| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2022 | 97.74% | Cowen & Co. | $9 → $7 | Maintains | Outperform |
| 10/21/2022 | 69.49% | Goldman Sachs | $7 → $6 | Maintains | Buy |
| 08/11/2022 | 125.99% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
| 05/12/2022 | 182.49% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 03/30/2022 | 210.73% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 10/19/2021 | 238.98% | Morgan Stanley | → $12 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 436.72% | Goldman Sachs | → $19 | Initiates Coverage On | → Buy |
| 10/19/2021 | 295.48% | Cowen & Co. | → $14 | Initiates Coverage On | → Outperform |
| 01/03/2019 | — | Benchmark | Upgrades | Hold → Speculative Buy | |
| 11/12/2018 | — | Benchmark | Downgrades | Speculative Buy → Hold |
What is the target price for Cue Health (HLTH)?
The latest price target for Cue Health (NASDAQ: HLTH) was reported by Cowen & Co. on November 14, 2022. The analyst firm set a price target for $7.00 expecting HLTH to rise to within 12 months (a possible 97.74% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cue Health (HLTH)?
The latest analyst rating for Cue Health (NASDAQ: HLTH) was provided by Cowen & Co., and Cue Health maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Cue Health (HLTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cue Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cue Health was filed on November 14, 2022 so you should expect the next rating to be made available sometime around November 14, 2023.
Is the Analyst Rating Cue Health (HLTH) correct?
While ratings are subjective and will change, the latest Cue Health (HLTH) rating was a maintained with a price target of $9.00 to $7.00. The current price Cue Health (HLTH) is trading at is $3.54, which is out of the analyst's predicted range.